Ryogen Awarded Patents on Three Human Genes
Ryogen LLC, a genetic company headquartered in Suffern, New York, has been awarded two patents on human genes by the USPTO. The patents  titled “Isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2” and “Isolated genomic polynucleotide fragments encoding human resistin and the human syntaxin binding protein 2” cover isolated genomic polynucleotide fragments.
T he claimed genes are directed to proteins, which are thought to play important roles in serious human diseases. Ryogen LLC is  planning to license these  patents and make these genes widely available for research to promote the development of new methods of genetic diagnostics and treatment.